Roffman Miller Associates Inc. PA Reduces Stock Holdings in Albemarle Co. (NYSE:ALB)

Roffman Miller Associates Inc. PA lowered its position in shares of Albemarle Co. (NYSE:ALB) by 9.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,681 shares of the specialty chemicals company’s stock after selling 5,321 shares during the period. Roffman Miller Associates Inc. PA’s holdings in Albemarle were worth $4,190,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in ALB. Union Bancaire Privee UBP SA purchased a new position in Albemarle in the 4th quarter valued at about $43,000. Fjarde AP Fonden Fourth Swedish National Pension Fund acquired a new stake in shares of Albemarle in the 4th quarter valued at about $491,000. Paradigm Asset Management Co. LLC bought a new position in shares of Albemarle during the fourth quarter worth about $121,000. Centricity Wealth Management LLC bought a new stake in shares of Albemarle in the 4th quarter valued at approximately $39,000. Finally, Alberta Investment Management Corp acquired a new position in Albemarle in the fourth quarter valued at approximately $1,529,000. 92.87% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Albemarle

In other news, CEO J Kent Masters sold 2,525 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The shares were sold at an average price of $101.12, for a total value of $255,328.00. Following the transaction, the chief executive officer now owns 73,747 shares in the company, valued at approximately $7,457,296.64. The trade was a 3.31 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 0.38% of the company’s stock.

Albemarle Stock Down 1.5 %

ALB opened at $81.26 on Monday. The company has a current ratio of 1.95, a quick ratio of 1.19 and a debt-to-equity ratio of 0.39. The stock’s fifty day simple moving average is $86.93 and its 200 day simple moving average is $92.23. Albemarle Co. has a 1-year low of $71.97 and a 1-year high of $143.19. The stock has a market cap of $9.55 billion, a PE ratio of -7.26, a price-to-earnings-growth ratio of 45.02 and a beta of 1.59.

Albemarle (NYSE:ALB) last issued its quarterly earnings results on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. As a group, research analysts expect that Albemarle Co. will post 0.11 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ALB. Oppenheimer reduced their price objective on Albemarle from $171.00 to $170.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Robert W. Baird dropped their target price on shares of Albemarle from $103.00 to $92.00 and set a “neutral” rating on the stock in a report on Wednesday, February 12th. Mizuho decreased their price target on Albemarle from $110.00 to $105.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. BMO Capital Markets dropped their price objective on shares of Albemarle from $150.00 to $140.00 in a research note on Wednesday, February 12th. Finally, Piper Sandler decreased their price objective on shares of Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a report on Thursday. Two analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $109.68.

About Albemarle

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.